St. Gallen 2011: Summary of the Consensus Discussion

Area of Science:

• Oncology
• Clinical Practice Guidelines
• Breast Cancer Research

Background:

• The 2011 St. Gallen Consensus Conference convened to establish global standards for early breast cancer management.
• Previous consensus meetings have significantly influenced clinical practice and treatment protocols worldwide.
• The need for updated, evidence-based recommendations addressing diverse treatment modalities was identified.

Purpose of the Study:

• To summarize the international panel's voting outcomes from the 2011 St. Gallen Consensus Conference.
• To present evidence-based treatment recommendations for early breast cancer care.
• To define a broad spectrum of acceptable clinical practices for global application.

Main Methods:

• International panel voting procedures were employed to reach consensus on treatment recommendations.
• The voting covered key areas including locoregional treatment, endocrine therapy, chemotherapy, and targeted therapy.
• Adjuvant bisphosphonate use was also a focus of the panel's deliberations and voting.

Main Results:

• The conference generated a comprehensive set of treatment recommendations for early breast cancer.
• A wide spectrum of clinically acceptable practices was endorsed, facilitating global implementation.
• Specific voting results for chemotherapy, targeted agents, endocrine treatments, and bisphosphonates were documented.

Conclusions:

• The 2011 St. Gallen Consensus provides a robust framework for evidence-based early breast cancer management.
• The recommendations aim to standardize and improve breast cancer care globally.
• The consensus reflects a broad agreement on acceptable therapeutic options, balancing efficacy and clinical feasibility.